Skip to main content

Advertisement

Case report - coronary vasospasm in transplanted heart: a puzzling phenomenon

  • 243 Accesses

Abstract

Background

Coronary artery spasm (CAS) is an underdiagnosed disease especially in heart transplant patients, and in those patients the etiology and pathophysiology remain largely unknown, although it has been associated with cardiac allograft vasculopathy or graft rejection.

Case presentation

We report the case of a heart-transplant patient whose cardiac graft experienced two coronary vasospasms: the first before transplantation, and the other at one-month of a postoperative course complicated by primary graft failure.

Conclusion

Our case illustrates that a transplanted heart predisposed with coronary vasospasm may suffer from early relapse in the recipient despite of complete post-surgical autonomic denervation. Exacerbated endothelial dysfunction of the donor heart after transplant, with the addition of systemic factors in the recipient may be involved in the genesis of this puzzling phenomenon.

Background

Coronary Artery Spasm (CAS) is a condition caused by the vasoconstriction of the epicardial coronary arteries, leading to myocardial ischemia that can play a role in various conditions, from rest angina to acute coronary syndrome. Several responsible mechanisms have been reported: abnormal autonomic nervous system, endothelial dysfunction, hyperreactivity of the coronary smooth muscle and, as recently demonstrated, specific anatomy of the coronary artery and inflammation of perivascular component, with a fundamental role played by inflammation of coronary adventitia and perivascular adipose tissue through Rho-kinase activation, one of the main molecular mediator in the mechanisms of coronary artery spasm in animals and humans [1,2,3].

CAS in heart transplant has previously been described to be rare [4]. Nevertheless, various degree of asymptomatic vasospasm may be observed during routine coronary angiography in transplanted hearts [5, 6], which suggests that only the most severe episodes may have overt clinical consequences, such as symptomatic ventricular arrhythmias, high-degree atrio-ventricular block, syncope, cardiac arrest, or even myocardial infarction in case of prolonged ischemia. Denervation of the transplanted heart explains the absence of angina in most cases, although some patients may be symptomatic due to late graft reinnervation [4, 7,8,9,10].

Since autonomic innervation is not necessary to develop CAS in heart transplant [4, 10], pathophysiology remains poorly understood and hypothetic. Endothelial damage caused by circulating neurohormonal, immunological or metabolic factors, is suspected to be the main trigger by altering vascular smooth muscle response. Peri-operative ischemia-reperfusion injuries, as well as preexisting preclinical atherosclerosis in the donor heart may also promote endothelial dysfunction and be responsible for abnormal vascular reactivity [8, 11, 12]. Moreover, CAS has been associated with acute rejection episodes and cardiac allograft vasculopathy (CAV), a form of accelerated atherosclerosis characterized by diffuse circumferential neointimal proliferation, which is recognized as the most important cause of long-term death in heart transplant patients. Therefore, CAS has been pointed out as a marker of poor prognosis in heart transplantation and may actually be the first manifestation of CAV [7, 13].

For the diagnosis, ECG changes in ST-T segments during chest symptoms, including good response to nitroderivates, is very important, but the gold standard is represented by Spasm Provocating Tests (SPT), using either Acethylcoline (Ach), either Ergonovine maleate (EM) or a combination of both (sequential SPT): the criteria of positivity is a > 90% transient stenosis of a coronary artery with signs/symptoms of myocardial ischemia [14, 15, 16].

Our case illustrates that a transplanted heart predisposed with coronary vasospasm may suffer from early relapse in the recipient despite of complete post-surgical autonomic denervation.

Case presentation

A 46 years old man with end-stage hypertrophic cardiomyopathy and electrical storm underwent urgent orthotopic heart transplantation: the donor was a 54 years old woman, known for diabetes, nicotine consumption, morbid obesity, combined ventilation disorder with restriction due to obesity hypoventilation syndrome and suspected chronic obstructive pulmonary disease, and history of thrombophilia (activated protein C resistance) with recurrent deep vein thrombosis and pulmonary embolism in cerebral death due to brain hemorrhage. Pre-transplant cardiac workup showed a 90% stenosis in the middle right coronary artery (Fig. 1), with normal LVEF, and no segmental wall-motion abnormalities or valvulopathy.

Fig. 1
figure1

Angiography in the donor heart. Arrow indicates critical stenosis on RCA

The technically uneventful transplant was completed with a venous coronary artery bypass graft (CABG) on the right coronary artery (RCA), with a total ischemic time of 191 min. After cross-clamp removal and appropriate induction therapy with methylprednisolone 500 mg IV, the heart showed severe global biventricular failure with severe functional mitral regurgitation. In the absence of preformed donor specific HLA antibodies in favor of an acute humoral rejection, primary graft failure was suspected, and mechanical hemodynamic support was immediately initiated with a central veno-arterial extracorporeal membrane oxygenation (ECMO) and intra-aortic balloon pump (IABP), and high dose of cathecolamines (Noradrenaline up to 30 mcg/min) A relatively low troponin release was observed during the first 24 h post-operative (peak at 2386 ng/l), favoring the hypothesis of myocardial stunning over necrosis.

A cardiac tamponade on post-operative day 1 led to surgical revision. The intra-operative status was noteworthy for an occlusion of the venous CABG on the RCA. A coronary angiogram was urgently performed in attempt to treat the stenosis in the native vessel. Surprisingly, only a < 50% stenosis could be seen the mid RCA (Fig. 2). It was then noticed that the angiogram performed in the donor had not been preceded by the administration of nitroglycerine, which retrospectively spoke for a severe localized vasospasm of the mid RCA at the site of an atherosclerotic plaque. No further intervention was performed and the ECMO could finally be weaned on day 9, after full recovery of the LV function and moderate persistent RV dysfunction.

Fig. 2
figure2

Angiography at day 1: Venous bypass is occluded: broad arrow indicates the anastomotic stump. Thin arrow indicated the < 50% stenosis

In stable phase, during his fourth post-transplant week at the intermediate care unit, the patient developed sustained ventricular tachycardia at rest, with a heart rate of 150 bpm and no associated hemodynamic instability or even symptoms. Rapid cardioversion was easily achieved with a single administration of 2 mg magnesium sulfate IV. Nevertheless, the immediate post-cardioversion 12-lead ECG and echocardiography respectively showed severe ST-segment elevation in the inferior leads (Fig. 3 and 4) with inferior and inferolateral hypokinesia (Additional files 1, 2 and 3). Urgent cardiac catheterization showed a severe localized coronary vasospasm in the proximal RCA (Fig. 5), which was rapidly reversed after intracoronary injection of 1 mg isosorbide dinitrate. The ECG and echocardiography quickly normalized after the acute event, without consecutive elevation of troponins. An endomyocardial biopsy excluded an acute cellular or humoral rejection. The patient was treated with diltiazem without further episodes of arrhythmias or ST-segment changes during his hospital stay.

Fig. 3
figure3

ECG: Ventricular tachycardia

Fig. 4
figure4

ECG: ST segment elevation in the inferior leads after cardioversion

Fig. 5
figure5

Angiography during right coronary artery vasospasm. Arrow indicates RCA vasospasm

Interestingly, a few days before this coronary vasospasm, the patient complained from recurrent abdominal pain followed by melena. A colonoscopy showed ulcerations in the distal ileum, correlated with reversible signs of bowel ischemia in two consecutive CT scans, without evidence of occlusion or embolization in the mesenteric vessels. We could speculate that systemic factors in the recipient might favor vasospastic events. Because of a previously reported case of segmental mesenteric ischemia related to mycophenolate mofetil [17], this drug was replaced by azathioprine without any further abdominal pain or bleeding episodes.

Discussion and conclusions

Three lessons can be learned from this case. First, vasospasm should never be forgotten as a possible cause of angiographic coronary stenosis, even in the setting of pre-transplant assessment: it may typically develop on the site of an atherosclerotic plaque, with the risk to overestimate the severity of a stenosis. In our case, this led to perform an unnecessary CABG in addition to transplant, which prolonged the ischemic time of these 54 years-old hearts over 3 h, and participated in the genesis of primary graft failure. The execution of provocation tests during the pre-transplant coronary angiogram could be considered for the early identification of this phenomenon in the donor heart: these tests have been proven to be not only safe but also useful to enhance the diagnostic value of a diagnostic angiography in the population suffering from vasospastic angina [18].

Secondly, it shows that coronary vasospasm may manifest very early in the recipient despite of complete autonomic denervation of the heart, and out of any context of graft rejection or cardiac graft vasculopathy. Although this was already reported [8], the particularity of our case is that a first coronary vasospasm could be documented in the donor during the pre-transplant coronary angiogram, which point out that this heart was sensitized to vasospasm in a context of preexistent atherosclerosis and probable endothelial dysfunction. Extensive ischemia-reperfusion injuries induced by the prolonged and severe primary graft failure and high doses of post-operative catecholamines may have exacerbated this dysfunction and favored vasospastic response.

Thirdly, our case shows that full heart recovery may still be possible after 9 days on ECMO support following primary graft failure with severe biventricular failure, which is longer compared to previously reported delays, usually ranging from 72 h to 7 days [19]. This could only be achieved through high-quality multidisciplinary care, which was life-saving for the patient. Whether CAS was also involved in primary graft failure in the immediate post-operative phase will never be known, though it has been reported elsewhere [14].

In conclusion, coronary vasospasm in heart-transplant patients is a complex and multi-faceted problem that is not limited to the context of graft rejection or cardiac graft vasculopathy. Independently of cardiac autonomic innervation, endothelial dysfunction - possibly induced by immunological, neurohormonal and metabolic factors – is now seen as the main trigger for this phenomenon, and may be exacerbated by ischemia-reperfusion injury in the near post-operative course. Our case identifies pre-existent atherosclerosis and vasospasm in the donor heart as a clear risk factor for early post-transplant vasospasm.

Availability of data and materials

Not applicable.

Abbreviations

Ach:

Acethylcoline

CABG:

Coronary artery bypass graft

CAS:

Coronary artery spasm

CAV:

Cardiac allograft vasculopathy

ECMO:

Extra-corporeal membrane oxygenation

EM:

Ergonovine maleate

IABP:

Intra-aortic balloon pump

LVEF:

Left ventricle ejection fraction

RCA:

Right coronary artery

SPT:

Spasm Provocating tests

References

  1. 1.

    Teragawa H, Oshita C, Ueda T. Coronary spasm: It’s common, but it's still unsolved. World J Cardiol. 2018;10(11):201–9. https://doi.org/10.4330/wjc.v10.i11.201.

  2. 2.

    Ohyama K, Matsumoto Y, Takanami K, et al. Coronary adventitial and perivascular adipose tissue inflammation in patients with Vasospastic angina. J Am Coll Cardiol. 2018;71(4):414–25. https://doi.org/10.1016/j.jacc.2017.11.046.

  3. 3.

    Ohyama K, Matsumoto Y, Takahashi J, Takanami K, Shimokawa H. Reply: new aspects of Vasospastic angina: coronary adventitial and perivascular adipose tissue inflammation. J Am Coll Cardiol. 2018;71(23):2709–10. https://doi.org/10.1016/j.jacc.2018.03.510.

  4. 4.

    Dalzell JR, Jackson CE, Petrie MC, Hogg KJ. Acute myocardial infarction due to coronary vasospasm in a heart transplant recipient. Am J Emerg Med. 2010;28(4):539.e1–4. https://doi.org/10.1016/j.ajem.2009.08.007.

  5. 5.

    Omondi A, Briceno D, Villablanca PA. Coronary vasospasm: a silent enemy in orthotopic heart transplant. Coron Artery Dis. 2018;29(1):86–7. https://doi.org/10.1097/MCA.0000000000000553.

  6. 6.

    Akgün NA, Çiftci O, Yılmaz KC, Karaçağlar E, Aydınalp A, Sezgin A, Müderrisoğlu IH, Haberal M. Prevalence and Angiographic Characteristics of Coronary Vasospasm Detected at Surveillance Coronary Angiograms Among Patients With Heart Transplants. Exp Clin Transplant. 2018;Suppl 1(Suppl 1):85–8.

  7. 7.

    Bisognano JD, Lindenfeld J, Hammond E, Zisman LS. Coronary artery vasospasm causing acute myocardial infarction in a heart transplant recipient. J Heart Lung Transplant. 2005;24(3):355–8.

  8. 8.

    Pistono M, Brentana L, Gnemmi M, Imparato A, Temporelli PL, Zingarelli E, Patané F, Giannuzzi P. Early right coronary vasospasm presenting with malignant arrhythmias in a heart transplantation recipient without allograft vasculopathy. Int J Cardiol. 2009;131(3):e120–3 Epub 2007 Oct 24.

  9. 9.

    Santoro F, Lopizzo A, Centola A, Cuculo A, Ruggiero A, Di Biase M, Brunetti ND. Very late coronary spasm inducing acute myocardial infarction in a heart transplant recipient. J Cardiovasc Med (Hagerstown). 2016;17(Suppl 2):e235–6.

  10. 10.

    Tayal R, Pieretti J, Baran DA. Severe systemic vasospasm causing recurrent cardiac arrest after orthotopic heart transplantation. J Heart Lung Transplant. 2013;32(12):1271–2.

  11. 11.

    Buda AJ, Fowles RE, Schroeder JS, Hunt SA, Cipriano PR, Stinson EB, Harrison DC. Coronary artery spasm in the denervated transplanted human heart: a clue to underlying mechanisms. Am J Med. 1981;70(5):1144–9.

  12. 12.

    Boffa GM, Livi U, Grassi G, Casarotto D, Isabella G, Cardaioli P, Panfili M, Chioin R. Angiographic presentation of coronary artery spasm in heart transplant recipients. Int J Cardiol. 2000;73(1):67–74.

  13. 13.

    Kounis GN, Kouni SA, Hahalis G, Gouvelou-Deligianni GV, Batsolaki M, Kounis NG. Coronary allograft vasculopathy and coronary vasospasm in heart transplant recipients: a manifestation of Kounis syndrome? Int J Cardiol. 2010;144(3):e48–50. https://doi.org/10.1016/j.ijcard.2008.12.061.

  14. 14.

    Sheu R, Berfield K, Jones S, Pal J, Mackensen GB. Intraoperative acute multivessel coronary vasospasm in cardiac allograft: a case report. A A Case Rep. 2017;9(11):328–31.

  15. 15.

    JCS Joint Working Group. Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) (JCS 2013). Circ J. 2014;78(11):2779–801.

  16. 16.

    Beltrame JF, Crea F, Kaski JC, Ogawa H, Ong P, Sechtem U, Shimokawa H. Bairey Merz CN; coronary Vasomotion disorders international study group (COVADIS). International standardization of diagnostic criteria for vasospastic angina. Eur Heart J. 2017;38(33):2565–8. https://doi.org/10.1093/eurheartj/ehv351.

  17. 17.

    Königsrainer A, Steurer W, Spechtenhauser B, Margreiter R, Rieger M, Waldenberger P. Nonocclusive segmental mesenteric ischemia after combined pancreas kidney transplantation: mycophenolate mofetil as an etiological factor? Transplantation. 2000;70(4):695–6.

  18. 18.

    Ciliberti G, Seshasai SRK, Ambrosio G, Kaski JC. Safety of intracoronary provocative testing for the diagnosis of coronary artery spasm. Int J Cardiol. 2017;244:77–83. https://doi.org/10.1016/j.ijcard.2017.05.109.

  19. 19.

    Iyer A, Kumarasinghe G, Hicks M, Watson A, Gao L, Doyle A, Keogh A, Kotlyar E, Hayward C, Dhital K, Granger E, Jansz P, Pye R, Spratt P, Macdonald PS. Primary graft failure after heart transplantation. J Transp Secur. 2011;2011:175768. https://doi.org/10.1155/2011/175768.

Download references

Acknowledgements

Data sharing is not applicable to this article as no datasets were generated or analysed during the current study.

Funding

No funding or sponsorship was received for this study or publication of this article.

Author information

MP conceived and designed the study, analyzed and reconstructed the patient clinical history and wrote the manuscript. JR analyzed and interpreted the patient data regarding the heart failure condition and substantively revised the manuscript. JA analyzed and interpreted the coronary angiograms and revised the manuscript. OM analyzed and interpreted the coronary angiograms. GR had a main role in the acquisition of patient data. PT conceived and designed the study, analyzed and interpreted the patient data regarding the surgical intervention and the post-operative course and substantively revised the work. All named authors were major contributors to the writing of the manuscript and the analysis and the interpretation of the patients data, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.

Correspondence to M. Pagnoni.

Ethics declarations

Ethics approval and consent to participate

Ethics approval is waived for case report.

Consent for publication

Written informed consent for publication of the patient’s clinical details was obtained, and a copy of the consent form is available for review.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Pagnoni, M., Regamey, J., Adjedj, J. et al. Case report - coronary vasospasm in transplanted heart: a puzzling phenomenon. BMC Cardiovasc Disord 19, 305 (2019). https://doi.org/10.1186/s12872-019-01280-8

Download citation

Keywords

  • Coronary artery spasm
  • Heart transplant
  • Ventricular tachycardia
  • Myocardial ischemia
  • Cardiac allograft vasculopathy
  • Endothelial dysfunction